MXPA03001607A - Nuevos macrolidos con actividad antibacteriana. - Google Patents

Nuevos macrolidos con actividad antibacteriana.

Info

Publication number
MXPA03001607A
MXPA03001607A MXPA03001607A MXPA03001607A MXPA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A
Authority
MX
Mexico
Prior art keywords
antibacterial activity
new macrolides
heterocyclyl
hydrogen
formula
Prior art date
Application number
MXPA03001607A
Other languages
English (en)
Inventor
Peter Angehrn
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of MXPA03001607A publication Critical patent/MXPA03001607A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MXPA03001607A 2000-08-22 2001-08-20 Nuevos macrolidos con actividad antibacteriana. MXPA03001607A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00117971 2000-08-22
PCT/EP2001/009560 WO2002016380A1 (en) 2000-08-22 2001-08-20 New macrolides with antibacterial activity

Publications (1)

Publication Number Publication Date
MXPA03001607A true MXPA03001607A (es) 2003-06-04

Family

ID=8169600

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001607A MXPA03001607A (es) 2000-08-22 2001-08-20 Nuevos macrolidos con actividad antibacteriana.

Country Status (14)

Country Link
US (1) US6740642B2 (es)
EP (1) EP1313751B1 (es)
JP (1) JP4162992B2 (es)
KR (1) KR100502031B1 (es)
CN (1) CN1234718C (es)
AT (1) ATE408614T1 (es)
AU (1) AU2001282105A1 (es)
BR (1) BR0113472A (es)
CA (1) CA2419296C (es)
DE (1) DE60135859D1 (es)
ES (1) ES2313975T3 (es)
MX (1) MXPA03001607A (es)
WO (1) WO2002016380A1 (es)
ZA (1) ZA200301047B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1727702A (en) * 2000-12-21 2002-07-01 Glaxo Group Ltd Macrolide antibiotics
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
WO2003024986A1 (en) * 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en) 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
US6765016B1 (en) 2003-06-05 2004-07-20 Enanta Pharmaceuticals, Inc. Bicyclic ketolide derivatives
US6790835B1 (en) 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US6774115B1 (en) 2003-06-05 2004-08-10 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic ketolides
US6716820B1 (en) 2003-06-05 2004-04-06 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic macrolides
WO2004108745A2 (en) * 2003-06-05 2004-12-16 Enanta Pharmaceuticals, Inc. 11-12 bicyclic erythromycin derivatives
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
WO2006065721A2 (en) * 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
CN101115764B (zh) * 2005-02-09 2012-09-26 巴斯利尔药物股份公司 大环内酯类化合物
PL1846430T3 (pl) 2005-02-09 2009-08-31 Basilea Pharmaceutica Ag Nowe makrolidy
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
US8278281B2 (en) 2005-08-24 2012-10-02 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
DK2049556T3 (da) 2006-08-09 2013-08-12 Basilea Pharmaceutica Ag Nye makrolider anvendelige mod inflammatoriske og allergiske sygdomme
WO2008023248A2 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
KR101617897B1 (ko) 2008-02-08 2016-05-03 바실리어 파마슈티카 아게 신규 마크로라이드 및 그의 용도
JP5769972B2 (ja) * 2008-02-08 2015-08-26 バジリア ファルマスーチカ アーゲーＢａｓｉｌｅａ Ｐｈａｒｍａｃｅｕｔｉｃａ ＡＧ Ｐｄｅ阻害により仲介される疾患を処置するためのマクロライド
BRPI1011959A2 (pt) 2009-05-27 2016-04-26 Wockhardt Research Center compostos de cetolídeo tendo atividade antimicrobiana.
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
CN102417530A (zh) * 2010-09-26 2012-04-18 中国医学科学院药物研究所 广谱抗菌素红霉素a大环酮内酯类衍生物的合成方法和用途
PL2673285T3 (pl) 2010-12-09 2017-12-29 Wockhardt Limited Związki ketolidowe
JP5718488B2 (ja) 2011-03-01 2015-05-13 ウォックハート リミテッド ケトライド中間体の調製方法
PL2938623T3 (pl) * 2012-12-31 2017-03-31 Basilea Pharmaceutica Ag Wybrane makrolidy o działaniu hamującym pde4
MX2018010652A (es) 2016-01-12 2021-07-16 Wockhardt Ltd Composiciones farmaceuticas.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
US20030199459A1 (en) 2003-10-23
ES2313975T3 (es) 2009-03-16
JP2004506740A (ja) 2004-03-04
EP1313751A1 (en) 2003-05-28
US6740642B2 (en) 2004-05-25
KR100502031B1 (ko) 2005-07-25
ZA200301047B (en) 2004-05-06
AU2001282105A1 (en) 2002-03-04
WO2002016380A1 (en) 2002-02-28
CA2419296A1 (en) 2002-02-28
CN1464880A (zh) 2003-12-31
CN1234718C (zh) 2006-01-04
KR20030029839A (ko) 2003-04-16
CA2419296C (en) 2008-12-09
DE60135859D1 (de) 2008-10-30
ATE408614T1 (de) 2008-10-15
JP4162992B2 (ja) 2008-10-08
BR0113472A (pt) 2003-07-01
EP1313751B1 (en) 2008-09-17

Similar Documents

Publication Publication Date Title
MXPA03001607A (es) Nuevos macrolidos con actividad antibacteriana.
FR2742757B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CA2284732A1 (en) Analogs of cocaine
MY146279A (en) Compounds affecting glucokinase
ATE541576T2 (de) 2'-o,4'-c-methylen bicyclonukleoside
CA2469813A1 (en) Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
CA2476884A1 (en) Macrolides with antibacterial activity
YU50002A (sh) Supstituisani piperidini, lekovi koji sadrže ova jedinjenja i postupci za njihovu proizvodnju
EP1256588A4 (en) NEW PYRAZINE DERIVATIVES OR SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVES OR THEIR SALTS AND INTERMEDIATES FOR BOTH PRODUCTION
UA73004C2 (uk) Біциклічні гетероцикли та лікувальний засіб на їх основі
PL350651A1 (en) 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
TR199801753T2 (xx) Pirimido(5,4-D) pirimidin bile�imini i�eren ila�lar, kullan�mlar� ve �retim i�lemleri.
AU2001295482A1 (en) Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
WO2006034822A8 (de) Neue substituierte thiophencarbonsäureamide, deren herstellung und deren verwendung als arzneimittel
DE69907419D1 (en) Antitumorwirkstoffe
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
HRP930014B1 (es)
WO1999004770A3 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
WO2000078956A8 (en) Novel pyrrhocoricin-derived peptides, and methods of use thereof
FR2804958B1 (fr) Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
EP0497978A4 (en) Cephalosporin compounds and production thereof
FR2760017B1 (fr) Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
PL351402A1 (en) Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
YU3701A (sh) Supstituisani fenilamidini sa antitrombskim dejstvom
YU30602A (sh) Primena 2-amino-3,4-dihidro-hinazolina za proizvodnju leka za lečenje ili profilaksu bolesti koje su prouzrokovane ishemičnim stanjima

Legal Events

Date Code Title Description
FG Grant or registration